Skip to main content
SpringerLink
Log in

Cushing’s disease, pseudo-Cushing states and the dexamethasone test: a historical and critical review

  • Published:
Pituitary Aims and scope Submit manuscript

Abstract

The dexamethasone (DXM) test has been widely used for diagnosing Cushing’s disease (CD). The purpose of this paper is to review its diagnostic merit based on calculation of data extracted from earlier publications. Studies presenting individual values for patients with CD and normal subjects were identified through PubMed searches and references in pertinent studies. Calculation of the retrieved data demonstrated huge variation in the relative suppressibility, negative suppression being common. Furthermore, in almost each study retrieved, the pre and post DXM values were closely correlated. Finally, the generally accepted view that DXM causes less suppression in Cushing’s disease than in euadrenal controls appears unfounded. A central issue in the definition of so-called “pseudo-Cushing’s states” is failure to suppress cortisol secretion with DXM. From analysis of the literature it appears quite possible that this does not reflect a specific endocrine deficit, but a physiological “stress” reaction. The above issues question the diagnostic value of the test, in particular in clinically and biochemically borderline cases.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Lindholm J (2000) Cushing’s syndrome: historical aspects. Pituitary 3:97–104

    Article  CAS  PubMed  Google Scholar 

  2. Cushing H (1912) The pituitary body and its disorders, clinical states produced by disorders of the hypophysis cerebri. Lippincott, Philadelphia, pp 1–341

    Google Scholar 

  3. Cushing H (1932) The basophilic adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). Bull Johns Hopkins Hosp 50:137–195

    Google Scholar 

  4. Kepler EJ (1949) Cushing’s disease: a primary disorder of the adrenal cortices. Ann NY Acad Sci 50:657–678

    Article  CAS  PubMed  Google Scholar 

  5. Bauer J (1950) The so-called Cushing’s syndrome, its history, terminology and differential diagnosis. Acta Med Scand 137:411–416

    Article  CAS  PubMed  Google Scholar 

  6. Norymberski JD, Stubbs RD, West HE (1953) Assessment of adrenocortical activity by assay of 17-ketogenic steroids in urine. Lancet 261:1276–1281

    Article  Google Scholar 

  7. Porter CC, Silber RH (1950) A quantitative color reaction for cortisone and related 17:21-dihydroxy-20-ketosteroids. J Biol Chem 185:201–207

    CAS  PubMed  Google Scholar 

  8. Schteingart DE, Gregerman RI, Conn JW (1963) A comparison of the characteristics of increased adrenocortical function in obesity and in Cushing’s syndrome. Metabolism 12:484–497

    CAS  PubMed  Google Scholar 

  9. Cope CL, Black EG (1959) The reliability of some adrenal function tests. BMJ 2:1117–1122

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  10. Beisel WR, Cos JJ, Horton R, Chao PY, Forsham PH (1964) Physiology of urinary cortisol. J Clin Endocrinol Metabol 24:887–893

    Article  CAS  Google Scholar 

  11. Lindholm J (1973) The urinary excretion of cortisol. Scand J Lab Clin Invest 31:115–118

    Article  CAS  Google Scholar 

  12. Wilkins L, Lewis R, Klein R, Rosenberg E (1950) The suppression of androgen secretion by cortisone in a case of congenital adrenal hyperplasia. Bull Johns Hopkins Hosp 86:249–252

    CAS  PubMed  Google Scholar 

  13. Jailer JW, Louchart J, Cahill GF (1952) Adrenal virilism. 1 Diagnostic consideration and treatment. JAMA 150:575–579

    Article  CAS  Google Scholar 

  14. Segaloff A, Gordon D, Horwitt BN (1955) Differential diagnosis of adrenal lesions by the use of intravenous administration of hydrocortisone. J Lab Clin Med 45:219–227

    CAS  PubMed  Google Scholar 

  15. Jailer JW, Louchart JWT, Gold JJ, Knowlton A, Cahill GF (1953) The effect of cortisone on the urinary excretion of 17-ketosteroids in patients with Cushing’s syndrome. J Clin Invest 32:449–451

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  16. Jailer JW, Gold JJ, Wallace EZ (1954) Evaluation of the “cortisone test” as a diagnostic aid in differentiating adrenal hyperplasia from adrenal neoplasia. Am J Med 16:340–345

    Article  CAS  PubMed  Google Scholar 

  17. Cope CL, Harrison RJ (1955) Effect of 9α-fluoro hydrocortisone on adrenal hyperfunction in Cushing’s syndrome. BMJ 2:457–460

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  18. Liddle GW (1960) Tests of pituitary-adrenal suppressibility in the diagnosis of Cushing’s syndrome. J Clin Endocrinol Metabol 20:1539–1560

    Article  CAS  Google Scholar 

  19. Nugent CA, Nichols T, Tayler FH (1965) Diagnosis of Cushing’s syndrome: single dose dexamethasone suppression test. Arch Intern Med 116:172–176

    Article  CAS  PubMed  Google Scholar 

  20. Pavlatos FC, Smilo RP, Forsham PH (1965) A rapid screening test for Cushing’s syndrome. JAMA 193:720–723

    Article  CAS  PubMed  Google Scholar 

  21. Kennedy L, Atkinson AB, Johnston H, Sheridan B, Hadden DR (1984) Serum cortisol concentrations during low dose dexamethasone suppression test to screen for Cushing’s syndrome. BMJ (Clin Res Ed) 289:1188–1191

    Article  CAS  Google Scholar 

  22. Odagiri E, Demura R, Demura H, Suda T, Ishiwatari N, Abe Y, Jibiki K, Shizume K (1988) The changes in plasma cortisol and urinary free cortisol by an overnight dexamethasone suppression test in patients with Cushing’s disease. Endocrinol Jpn 35:795–802

    Article  CAS  PubMed  Google Scholar 

  23. Barth JH, Seth J, Howlett TA, Freedman DB (1995) A survey of endocrine function testing by clinical biochemistry laboratories in the UK. Ann Clin Biochem 32:442–449

    Article  PubMed  Google Scholar 

  24. Cope CL (1966) The adrenal cortex in internal medicine I. BMJ 2:847–853

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  25. Burke CW, Beardwell CG (1973) Cushing’s syndrome. An evaluation of the clinical usefulness of urinary free cortisol and other urinary steroid measurements in diagnosis. QJM 42:175–204

    CAS  PubMed  Google Scholar 

  26. Meikle AW (1982) Dexamethasone suppression tests: usefulness of simultaneous measurement of plasma cortisol and dexamethasone. Clin Endocrinol 16:401–408

    Article  CAS  Google Scholar 

  27. Croughs RJ, Docter R, de Jong FH (1973) Comparison of oral and intravenous dexamethasone suppression tests in the differential diagnosis of Cushing’s syndrome. Acta Endocrinol 72:54–62

    CAS  PubMed  Google Scholar 

  28. Orth DN (1984) The old and the new in Cushing’s syndrome. N Engl J Med 310:649–657

    Article  CAS  PubMed  Google Scholar 

  29. Eddy RL, Jones AL, Gilliland PF, Ibarra JD, Thompson JQ, McMurry JF (1973) Cushing’s syndrome: a prospective study of diagnostic methods. Am J Med 55:621–630

    Article  CAS  PubMed  Google Scholar 

  30. Tran HA, Petrovsky N (2005) Dexamethasone infusion testing in the diagnosis of Cushing’s syndrome. Endocr J 52:103–109

    Article  PubMed  Google Scholar 

  31. McHardy-Young S, Harris PWR, Lessof MH, Lyne G (1967) Single-dose dexamethasone suppression test for Cushing’s syndrome. BMJ 2:740–744

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  32. Nieman LK (2002) Diagnostic tests for Cushing’s syndrome. Ann NY Acad Sci 970:112–118

    Article  CAS  PubMed  Google Scholar 

  33. Arnaldi G, Angeli A, Atkinson AB, Bertagna X, Cavagnini F, Chrousos GP, Fava GA, Findling JW, Gaillard RC, Grossman AB, Kola B, Lacroix A, Mancini T, Mantero F, Newell-Price J, Nieman LK, Sonino N, Vance ML, Giustina A, Boscaro M (2003) Diagnosis and complications of Cushing’s syndrome: a consensus statement. J Clin Endocrinol Metab 88:5593–5602

    Article  CAS  PubMed  Google Scholar 

  34. Isidori AM, Kaltsas GA, Mohammed S, Morris DG, Jenkins P, Chew SL, Monson JP, Besser GM, Grossman AB (2003) Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing’s syndrome. J Clin Endocrinol Metabol 88:5299–5306

    Article  CAS  Google Scholar 

  35. Newell-Price J, Bertagna X, Grossman AB, Nieman LK (2006) Cushing’s syndrome. Lancet 367:1605–1617

    Article  CAS  PubMed  Google Scholar 

  36. Kola B, Grossman AB (2008) Dynamic testing in Cushing’s syndrome. Pituitary 11:155–162

    Article  CAS  PubMed  Google Scholar 

  37. Nieman LK, Biller BM, Findling JW, Newell-Price J, Savage MO, Stewart PM, Montori VM (2008) The diagnosis of Cushing’s syndrome: an Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metabol 93:1526–1540

    Article  CAS  Google Scholar 

  38. Suda T, Kageyama K, Nigawara T, Sakihara S (2009) Evaluation of diagnostic tests for ACTH-dependent Cushing’s syndrome. Endocr J 56:469–476

    Article  CAS  PubMed  Google Scholar 

  39. Branconnier RJ, Oxenkrug GF, McIntyre I, Pomara N, Harto NE, Gershon S (1984) Prediction of serum cortisol response to dexamethasone in normal volunteers: a multivariate approach. Psychopharmacology 84:274–275

    Article  CAS  PubMed  Google Scholar 

  40. Lindholm J (1992) Endocrine studies in patients with Cushing’s disease before and after treatment. Clin Endocrinol 36:151–159

    Article  CAS  Google Scholar 

  41. Findling JW, Raff H, Aron DC (2004) The low-dose dexamethasone suppression test: a reevaluation in patients with Cushing’s syndrome. J Clin Endocrinol Metabol 89:1222–1226

    Article  CAS  Google Scholar 

  42. Friedman TC (2006) An update on the overnight dexamethasone suppression test for the diagnosis of Cushing’s syndrome: limitations in patients with mild and/or episodic hypercortisolism. Exp Clin Endocrinol Diabetes 114:356–360

    Article  CAS  PubMed  Google Scholar 

  43. Board F, Wadeson R, Hamburg D (1956) Psychological stress and endocrine functions. Psychosom Med 18:324–333

    Article  CAS  PubMed  Google Scholar 

  44. Carroll BJ, Martin FI, Davies B (1968) Resistance to suppression by dexamethasone of plasma 11-OHCS levels in severe depressive illness. BMJ 3:285–287

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  45. Georgotas A, McCue RE, Kim OM, Hapworth WE, Reisberg B, Stoll PM, Sinaiko E, Fanelli C, Stokes PE (1986) Dexamethasone suppressionin dementia, depression, and normal aging. Am J Psychiatry 143:452–456

    CAS  PubMed  Google Scholar 

  46. Coppen A, Abou-Saleh M, Milln P, Metcalfe M, Harwood J, Bailey J (1983) Dexamethasone suppression test in depression and other psychiatric illness. Br J Psychiatry 142:498–504

    Article  CAS  PubMed  Google Scholar 

  47. Gruen PH (1978) Endocrine changes in psychiatric diseases. Med Clin N Am 62:285–295

    CAS  PubMed  Google Scholar 

  48. Brouwer JP, Appelhof BC, Hoogendijk WJ, Huyser J, Endert E, Zuketto C, Schene AH, Tijssen JG, Van Dyck R, Wiersinga WM, Fliers E (2005) Thyroid and adrenal axis in major depression: a controlled study in outpatients. Eur J Endocrinol 152:185–191

    Article  CAS  PubMed  Google Scholar 

  49. Rush A, Giles D, Schlesser M, Orsulak P, Weissenburger J, Fulton C, Fairchild C, Roffwarg H (1997) Dexamethasone response, thyrotropin-releasing hormone stimulation, rapid eye movement latency, and subtypes of depression. Biol Psychiatry 41:915–928

    Article  CAS  PubMed  Google Scholar 

  50. Hasselbalch H, Selmer J, Sestoft L, Kehlet H (1982) Hypothalamic-pituitary-adrenocortical function in chronic alcoholism. Clin Endocrinol 16:73–76

    Article  CAS  Google Scholar 

  51. Davis JRE, Jeffcoate WJ (1983) Lack of effect of ethanol on plasma cortisol in man. Clin Endocrinol 19:461–466

    Article  CAS  Google Scholar 

  52. Bishop MC, Ross EJ (1971) Adrenocortical activity in disseminated malignant disease in relation to prognosis. Br J Cancer 25:719–725

    Google Scholar 

  53. Jenkins PJ, Sohaib SA, Trainer PJ, Lister TA, Besser GM, Reznek R (1999) Adrenal enlargement and failure of suppression of circulating cortisol by dexamethasone in patients with malignancy. Br J Cancer 80:1815–1819

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  54. Reincke M, Allolio B, Wurth G, Winkelmann W (1993) The hypothalamic-pituitary-adrenal axis in critical illness: response to dexamethasone and corticotropin-releasing hormone. J Clin Endocrinol Metab 77:151–156

    CAS  PubMed  Google Scholar 

  55. Perrot D, Bonneton A, Dechaud H, Motin J, Pugeat M (1993) Hypercortisolism in septic shock is not suppressible by dexamethasone infusion. Crit Care Med 21:396–401

    Article  CAS  PubMed  Google Scholar 

  56. Chiodini I (2011) Diagnosis and treatment of subclinical hypercortisolism. J Clin Endocrinol Metab 96:1223–1236

    Article  CAS  PubMed  Google Scholar 

  57. Arnaldi G, Boscaro M (2012) Adrenal incidentaloma. Best Pract Res Clin Endocrinol Metab 26:405–419

    Article  CAS  PubMed  Google Scholar 

  58. Stewart PM (2010) Is subclinical Cushing’s syndrome an entity or a statistical fallout from diagnostic testing? Consensus surrounding the diagnosis is required before optimal treatment can be defined. J Clin Endocrinol Metabol 95:2618–2620

    Article  CAS  Google Scholar 

  59. Tyrrell JB, Findling JW, Aron DC, Fitzgerald PA, Forsham PH (1986) An overnight high-dose dexamethasone suppression test for rapid differential diagnosis of Cushing’s syndrome. Ann Intern Med 104:180–186

    Article  CAS  PubMed  Google Scholar 

  60. Grossman AB, Howlett TA, Perry L, Coy DH, Savage MO, Lavender P, Rees LH, Besser GM (1988) CRF in the differential diagnosis of Cushing’s syndrome: a comparison with the dexamethasone suppression test. Clin Endocrinol 29:167–178

    Article  CAS  Google Scholar 

  61. Blunt SB, Sandler LM, Burrin JM, Joplin GF (1990) An evaluation of the distinction of ectopic and pituitary ACTH dependent Cushing’s syndrome by clinical features: biochemical tests and radiological findings. QJM 77:1113–1133

    Article  CAS  PubMed  Google Scholar 

  62. Al-Saadi N, Diederich S, Oelkers W (1998) A very high dose dexamethasone suppression test for differential diagnosis of Cushing’s syndrome. Clin Endocrinol 48:45–51

    Article  CAS  Google Scholar 

  63. Lindholm J, Juul S, Jørgensen JOL, Astrup J, Bjerre P, Hagen C, Jørgensen J, Kosteljanetz M, Kristensen LØ, Laurberg P, Feldt-Rasmussen U, Schmidt K, Weeke J (2001) Incidence and late prognosis of Cushing’s syndrome: a population based study. J Clin Endocrinol Metabol 86:117–123

    CAS  Google Scholar 

Download references

Acknowledgments

The author declares that he has no conflict of interest.

Author information

Authors and Affiliations

  1. Department of Endocrinology, Aalborg University Hospital, 9000, Aalborg, Denmark

    J. Lindholm

Authors
  1. J. Lindholm
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to J. Lindholm.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lindholm, J. Cushing’s disease, pseudo-Cushing states and the dexamethasone test: a historical and critical review. Pituitary 17, 374–380 (2014). https://doi.org/10.1007/s11102-013-0509-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11102-013-0509-x

Keywords

Search

Navigation